Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nasal Administration of the NeuroEPO in Parkinson Disease: Short-term Tolerance Physician Lead Trial

NCT04110678 is registered in ClinicalTrials.gov with International Center for Neurological Restoration, Cuba as lead sponsor.

NCT NCT04110678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04110678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nasal Administration of the NeuroEPO in Parkinson Disease: Short-term Tolerance Physician Lead Trial
Lead sponsor
International Center for Neurological Restoration, Cuba
Phase
Phase 1/2
Overall status
Completed
Start date
November 1, 2015
Completion date
January 1, 2017
Enrollment
26 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease